BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

NCT06123884 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Recombinant humanized anti-PD-1 monoclonal antibody injection
DRUG: Cisplatin
DRUG: Bevacizumab Injection
DRUG: carboplatin
DRUG: Paclitaxel for Injection

Sponsor

Bio-Thera Solutions